Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Result of AGM

18 May 2012 11:57

RNS Number : 6659D
Ark Therapeutics Group PLC
18 May 2012
 



Results of Annual General Meeting

 

 

London, UK, 18 May 2012: At the Annual General Meeting of Ark Therapeutics Group plc (LSE: AKT) held yesterday all resolutions were passed. A summary of the proxy voting will be published in the Investor Relations section of the Company's website at www.arktherapeutics.com

 

A copy of the approved resolutions will be submitted to the National Storage Mechanism and will shortly be available for inspection at: www.hemscott.com/nsm.do

Due to statutory time limits on notice periods for shareholder meetings, it was not possible for shareholder approval to be sought to ratify Dr Venables' appointment at yesterday's AGM. As a result, Dr David Venables, Ark's newly appointed Executive Director - Manufacturing Services, stood down as a Director at yesterday's AGM but was immediately re-appointed as a Director by the Board. His re-appointment will be put to shareholders at the Company's AGM to be held in 2013.

 

 

Enquiries:

 

Ark Therapeutics Group plc

Dr Edward Bliss, Company Secretary

+44 (0)20 7388 7722

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGSFMFSAFESEII

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS